• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

How can sentinel node biopsy, isolated limb chemotherapy treat regional, recurrent melanoma?

Article

New York - The sentinel node biopsy was first introduced by Donald Morton, M.D., from the John Wayne Cancer Institute in 1992 as an attractive alternative to a complete lymph node dissection. One objective of sentinel node biopsy has been to reduce the morbidity associated with an elective lymph node dissection without sacrificing accurate pathological examination. However, it has also been suggested that sentinel node biopsy might improve patient outcome.

Related Videos
Elizabeth Kiracofe, MD, FAAD, and Jenny Murase, MD, experts on atopic dermatitis
Elizabeth Kiracofe, MD, FAAD, and Jenny Murase, MD, experts on atopic dermatitis
This series features 1 KOL.
This series features 1 KOL.
4 KOLs are featured on this panel.
4 KOLs are featured on this panel.
Latanya Benjamin, MD, FAAD, FAAP, an expert on vitiligo
Latanya Benjamin, MD, FAAD, FAAP, an expert on vitiligo
Latanya Benjamin, MD, FAAD, FAAP, an expert on vitiligo
Latanya Benjamin, MD, FAAD, FAAP, an expert on vitiligo
© 2024 MJH Life Sciences

All rights reserved.